IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Recent alerts have included:

• Invasive Haemophilus influenzae Type B Disease in Young Children and Importance for All Young Children to Receive 3 Dose Primary Series with Available Hib-containing Vaccine

IDSA members can sign up for these alerts online. (You must be logged in to have access to this link.)

In addition, FDA has launched a new hepatitis list serve. This new e-mail list will provide updates on safety and regulatory issues related to hepatitis B and C products. The e-mail list is intended to provide one source for FDA information on a variety of topics related to hepatitis B and C, including proposed regulatory guidances, opportunity to comment, and notices of upcoming public meetings. Sign up on FDA’s web page. (Please note that this page does not mention the hepatitis list serve. However, users receive notification that they have subscribed to the hepatitis list serve after they enter an e-mail address.)

Is Your Facility Experiencing Antibiotic Shortages?
Report these to FDA and IDSA.

How useful is this article?

< Previous Article | Next Article >